🇺🇸 FDA
Patent

US 12222355

Therapeutic antibodies against ROR-1 protein and methods for use of same

granted A61KA61K2039/505A61P

Quick answer

US patent 12222355 (Therapeutic antibodies against ROR-1 protein and methods for use of same) held by The Regents of the University of California expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/02